Albireo Reports Q2 2020 Financial Results and Provides Business Update
— Completed last patient visits in Phase 3 PFIC and Phase 2 NASH Trials —— Enrolled first biliary atresia patients in […]
InflaRx to Present at Upcoming Virtual Investor Events
JENA, Germany, Aug. 06, 2020 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by […]
Kelly® Reports Second Quarter Earnings
Financial HighlightsQ2 revenue declined 28.7% or 27.7% in constant currencyQ2 operating earnings of $11.1 million, down 68.2%, or down 50.4% […]
Selecta Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Updates
Closed strategic licensing agreement with Sobi for SEL-212 for $100 million in initial payments and up to $630 million in […]
Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update
Enrollment in our Phase 2 clinical trial program for ELX-02 in cystic fibrosis has been resumed in Europe and Israel […]
Intellia Therapeutics Announces Second Quarter 2020 Financial Results
Submitted first regulatory application to the U.K.’s MHRA to initiate a Phase 1 study of NTLA-2001 for the treatment of […]
Alico, Inc. Announces Two New Appointments to the Board of Directors
FORT MYERS, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announces the […]
US Tier-1 Mobile Operator Awards Gilat a Multi-Million Dollar Service Contract for Cellular Backhaul
PETAH TIKVA, Israel, Aug. 06, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in […]
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
New Drug Application for Epsolay® Submitted; Twyneo® New Drug Application on track for 2H 2020Top-line generic product revenue of $1.1 […]
Myriad to Announce Fiscal Fourth-Quarter and Full Fiscal Year 2020 Financial Results on August 13, 2020
SALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
